221: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricing

Are biotech's fortunes finally changing? Is Big Science impeding actual science? And what will Medicare negotiation mean for drug prices? STAT's Jason Mast joins us to discuss Jim Wilson, a pioneering scientist synonymous with the rise of gene therapy who staffers say presided over a toxic, abusive workplace. We also explain the latest news in the life sciences, including a multibillion-dollar deal, a novel approach to treating schizophrenia, and what the Senate drug pricing legislation means for the pharmaceutical industry.

Episode metadata supplied by the publisher feed · Published Aug 11, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

221: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricing

0:00 29:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 29 minutes long.

When was this The Readout Loud episode published?

This episode was published on August 11, 2022.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!